ACRS vs INDP: stock comparison and AI forecast
Aclaris Therapeutics, Inc. (ACRS) and Indaptus Therapeutics, Inc. (INDP) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ACRS Aclaris Therapeutics, Inc.
- Price
- $3.74 -21.3% · 6M
- Market Cap
- $551M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
INDP Indaptus Therapeutics, Inc.
- Price
- $3.24 +55.0% · 6M
- Market Cap
- $498M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- ACRS is 1.1 times larger than INDP by market capitalization ($551M against $498M).
- Over the last six months INDP returned +55.0% and ACRS -21.3%.
- ACRS carries 0.44 times debt per unit of equity, against 0.05 times for INDP.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ACRS | INDP |
|---|---|---|
| Market Cap | $551M | $498M |
| P/B Ratio | 4.42x | 43.75x |
| EPS | $-0.55 | $-3.55 |
| Book Value/Share | $0.85 | $0.07 |
| Revenue/Share | $0.06 | – |
| FCF/Share | $-0.42 | – |
Profitability & Margins
| Metric | ACRS | INDP |
|---|---|---|
| ROE | -60.8% | – |
| ROA | -42.1% | – |
| ROIC | -57.0% | – |
| Gross Margin | 79.5% | – |
| Operating Margin | -1050.2% | – |
| Net Margin | -921.5% | – |
| EBT Margin | -983.6% | – |
Financial Health
| Metric | ACRS | INDP |
|---|---|---|
| Current Ratio | 3.46x | – |
| D/E Ratio | 0.44x | 0.05x |
| Financial Leverage | 1.44x | 1.05x |
| Interest Coverage | -665.0x | – |
| Working Capital | $70M | – |
Cash Flow
| Metric | ACRS | INDP |
|---|---|---|
| Operating Cash Flow | -$62M | -$15M |
| Free Cash Flow | -$62M | – |
| Capital Spending | -$120K | – |
| FCF/Sales | -756.5% | – |
| CapEx/Sales | 1.4% | – |
Operational Efficiency
| Metric | ACRS | INDP |
|---|---|---|
| Asset Turnover | 0.05x | – |
| Fixed Assets Turnover | 12.4x | – |
| Payables Period | 3365 days | – |
Income Statement
| Metric | ACRS | INDP |
|---|---|---|
| Total Revenue | $8M | – |
| Operating Income | -$86M | -$15M |
| Net Income | -$76M | – |
| R&D Expense | $63M | $5M |
| Cost of Goods Sold | $2M | – |
Dividend & Shareholder Information
| Metric | ACRS | INDP |
|---|---|---|
| Shares Outstanding | 147M | 154M |
ACRS vs INDP: stock comparison and AI forecast
Which is bigger, ACRS or INDP?
ACRS is 1.1 times larger than INDP by market capitalization ($551M against $498M).
Which stock performed better over the last six months, ACRS or INDP?
Over the last six months INDP returned +55.0% and ACRS -21.3%.
Which one does Intratio's AI model rank higher, ACRS or INDP?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.